Anshika Jain
Healthcare is increasingly driven by data generated through electronic health records, insurance claims, clinical registries, medical devices, laboratory systems, patient-generated data, and digital health platforms. These real-world data sources provide an unprecedented opportunity to understand disease progression, evaluate treatments, identify risk factors, and improve healthcare delivery. However, transforming observational healthcare data into reliable evidence about cause and effect remains one of the most difficult challenges in modern health analytics.
Conventional statistical analytics are highly effective for describing patterns, measuring associations, estimating distributions, and identifying correlations between variables. However, association does not necessarily imply causation. A statistical relationship between a treatment and an outcome, for example, does not automatically demonstrate that the treatment caused the observed outcome. Patients receiving a particular treatment may differ systematically from untreated patients in ways that also influence their outcomes.
Causal inference addresses this fundamental problem by asking a different question: what would have happened to the same patient under an alternative intervention or exposure? Because it is impossible to observe multiple treatment scenarios for the same individual at the same point in time, causal inference requires carefully designed assumptions, analytical methods, and study frameworks to estimate these unobserved counterfactual outcomes.
Real-world healthcare data make causal inference particularly challenging because they are collected primarily for clinical care, administration, reimbursement, and operational purposes rather than for controlled experimentation. They therefore contain missing information, measurement errors, treatment-selection biases, changing clinical practices, and complex relationships between patient characteristics and outcomes. Moving beyond conventional statistical analytics requires recognizing these limitations and developing analytical frameworks capable of addressing the causal structure underlying healthcare data.
From Association to Causation
Traditional statistical analysis often begins by identifying relationships among variables. Researchers may observe that patients receiving a particular medication have different rates of hospitalization than patients who do not receive that medication. A conventional analysis might adjust for measured demographic or clinical variables and estimate an association between treatment and hospitalization.
The causal question is more demanding. Researchers want to know what difference the treatment itself made to patient outcomes. This requires distinguishing the effect of the intervention from the effects of the characteristics that influenced who received the intervention in the first place.
The distinction can be illustrated through a simple example. Suppose patients with severe disease are more likely to receive an intensive treatment. If these patients subsequently experience higher mortality, a simple comparison could suggest that the treatment is associated with increased mortality. Yet disease severity itself may be responsible for much of the observed difference. The treatment and the outcome are connected, but the association cannot automatically be interpreted as evidence that the treatment caused the outcome.
Causal inference attempts to address such problems by explicitly defining a causal question, identifying relevant confounding variables, and estimating what outcomes might have occurred under alternative treatment conditions.
The Role of Real-World Healthcare Data
Real-world healthcare data differ fundamentally from data generated through randomized controlled trials. In a randomized trial, treatment assignment is deliberately controlled, allowing researchers to reduce systematic differences between treatment groups. Randomization creates a strong foundation for estimating causal effects because, under appropriate conditions, treatment assignment is independent of potential outcomes.
Real-world data generally lack this experimental structure. Physicians choose treatments based on clinical judgment, patient preferences, disease severity, comorbidities, previous treatment response, resource availability, and other factors. Patients may seek care at different institutions and may differ substantially in their healthcare utilization.
Despite these limitations, real-world data have considerable value. They can contain large and diverse populations, long periods of follow-up, information about routine clinical practice, and patient groups that may be underrepresented in conventional trials. They can also provide evidence about treatment effectiveness in everyday clinical environments.
The central challenge is therefore not whether real-world data are useful, but how their observational nature can be accounted for when attempting to make causal claims.
Confounding and Treatment Selection
Confounding is one of the most important challenges in causal inference. A confounder is a variable associated with both the treatment or exposure and the outcome and can create a misleading relationship between them.
In healthcare, confounding is extremely common because treatment decisions are rarely random. Physicians may prescribe a medication because a patient has particular symptoms, laboratory abnormalities, or disease severity. Those same factors may independently influence the patient’s outcome.
Age, socioeconomic circumstances, disease severity, comorbidities, previous treatment, healthcare utilization, and clinical history can all influence treatment selection and outcomes. Some confounders may be measured accurately in healthcare databases, while others may be incompletely recorded or absent altogether.
Statistical adjustment can address measured confounding when appropriate assumptions are satisfied. Methods such as propensity scores, inverse probability weighting, regression adjustment, matching, and doubly robust estimators are widely used to create more comparable groups. However, these methods cannot automatically eliminate the influence of variables that were never measured or were measured poorly.
Consequently, causal inference depends not only on sophisticated statistical methods but also on understanding the clinical processes that generated the data.
The Counterfactual Framework
A central concept in causal inference is the counterfactual. For each patient, researchers can conceptually define two potential outcomes: the outcome that would occur if the patient received a particular treatment and the outcome that would occur if the same patient did not receive that treatment.
Only one of these outcomes can normally be observed for an individual. This is often described as the fundamental problem of causal inference. Researchers therefore use data from populations of individuals to estimate the missing counterfactual outcome.
The counterfactual framework encourages researchers to formulate precise causal questions before selecting analytical methods. Instead of asking whether a treatment is associated with lower mortality, a study might ask what the average difference in mortality would be if a defined population received the treatment compared with what would have occurred if the same population had followed a specified alternative treatment strategy.
This formulation requires clear definitions of the population, intervention, comparator, outcome, timing, and follow-up period. Without such definitions, even technically sophisticated analyses can produce results that are difficult to interpret causally.
Time-Varying Treatments and Disease Progression
Healthcare data are inherently temporal. Patients receive multiple treatments over time, disease severity changes, laboratory measurements fluctuate, and clinical decisions respond to evolving circumstances.
This creates additional complications for causal inference. A variable measured during treatment may itself be influenced by previous treatment and may subsequently affect future treatment decisions. Such variables can function as both consequences of earlier treatment and predictors of later treatment.
Conventional adjustment methods may produce bias when these time-dependent relationships are handled incorrectly. Advanced causal methods, including marginal structural models and longitudinal g-methods, have been developed to address situations in which treatment and confounding variables change over time.
For example, in chronic disease management, a patient’s clinical status may influence medication changes, while previous medications may influence future clinical status. Understanding the causal effect of a long-term treatment strategy requires modeling these dynamic relationships rather than treating the patient’s characteristics as fixed baseline variables.
Missing Data and Measurement Error
Real-world healthcare datasets are rarely complete. Laboratory tests may only be ordered for patients considered at risk. Diagnoses may be incompletely documented. Medication lists may not accurately reflect actual medication use. Social and behavioral factors may be poorly recorded.
Missingness is therefore not simply a technical inconvenience. The pattern of missing data can itself contain information about clinical decision-making. A laboratory test may be missing because the physician considered it unnecessary, because the patient did not attend follow-up, or because the healthcare system lacked access to the test.
Measurement error creates another challenge. Variables such as disease severity, medication adherence, symptom intensity, and lifestyle behaviors may be represented imperfectly in administrative or clinical databases. Incorrect measurements can weaken confounding adjustment and potentially distort estimated causal effects.
Researchers must therefore understand how data were generated rather than treating every variable in a dataset as an equally reliable representation of reality.
Selection Bias and Healthcare Access
Selection bias occurs when the individuals represented in an analysis differ systematically from the population about whom researchers want to draw conclusions. Real-world healthcare data can be particularly vulnerable to this problem.
Patients who receive care within a particular healthcare system may differ from individuals who do not seek care, lack access to healthcare, or receive treatment elsewhere. Patients who undergo specific tests may also differ systematically from those who do not.
For example, a study using hospital records may provide detailed information about hospitalized patients but may not represent individuals with milder disease who are treated in primary care or do not seek medical attention. Similarly, digital health datasets may disproportionately represent individuals with reliable internet access, smartphones, or willingness to use health applications.
These selection mechanisms can affect both internal validity and generalizability. A causal estimate may be valid for the observed population while not necessarily applying to a broader population.
Data Quality and Clinical Context
Causal inference cannot be separated from data quality. Large datasets do not automatically produce reliable causal evidence. Healthcare databases may contain duplicate records, inconsistent coding, delayed documentation, changes in clinical terminology, and differences between institutions.
Clinical context is equally important. A treatment may appear ineffective because it was preferentially given to patients with advanced disease. A diagnostic procedure may appear associated with poor outcomes because it is more commonly used in patients who are already critically ill.
Researchers therefore need domain knowledge to interpret relationships within healthcare data. Causal inference is not simply a computational exercise. Statistical methods should be combined with clinical understanding, knowledge of treatment pathways, and careful examination of how healthcare decisions are made.
Causal Diagrams and Structural Thinking
Causal diagrams provide an important framework for reasoning about complex healthcare relationships. Directed acyclic graphs, commonly known as DAGs, can represent assumptions about how variables influence one another.
For example, a causal diagram can help researchers determine whether a variable should be adjusted for, whether it represents a confounder, or whether adjusting for it could introduce bias. This is especially important because statistical adjustment is not universally beneficial. Controlling for the wrong variable can sometimes block part of a genuine causal pathway or introduce a spurious association.
Causal diagrams encourage researchers to make their assumptions explicit before conducting the analysis. This can improve study design and reduce the temptation to select adjustment variables solely because they improve statistical fit.
Modern Causal Inference and Machine Learning
Machine learning has created new opportunities for causal inference by providing flexible approaches to modeling complex relationships. Traditional regression models often require researchers to specify functional forms and interactions. Machine learning methods can model nonlinear relationships and high-dimensional data more flexibly.
Causal machine learning methods include approaches designed to estimate heterogeneous treatment effects, identify individuals or populations who may respond differently to an intervention, and combine outcome modeling with treatment-assignment modeling.
Techniques such as causal forests, targeted learning, Bayesian approaches, and doubly robust machine learning can help address complex causal questions. However, machine learning does not eliminate the fundamental assumptions required for causal inference. A highly accurate predictive model cannot automatically establish causation.
This distinction is crucial. Prediction asks what is likely to happen based on observed information, whereas causal inference asks what would happen under an intervention or change in exposure. These are related but fundamentally different objectives.
Heterogeneous Treatment Effects
Average treatment effects can conceal substantial differences between individuals. A treatment may provide considerable benefit to one group while offering little benefit to another, or it may produce different levels of risk depending on patient characteristics.
Real-world healthcare data provide an opportunity to investigate these heterogeneous treatment effects because they can contain large populations with diverse clinical characteristics. Causal machine learning can potentially identify patterns in treatment response across age groups, disease stages, comorbidity profiles, or other clinically meaningful characteristics.
However, estimates of individualized treatment effects must be interpreted carefully. Discovering apparent differences in treatment effects can be affected by multiple testing, limited sample sizes within subgroups, measurement error, and residual confounding. Such findings therefore require appropriate validation before being incorporated into clinical decision-making.
Target Trial Emulation
One influential approach to causal analysis using observational data is target trial emulation. The central idea is to define the hypothetical randomized trial that would ideally answer the research question and then reproduce its essential design elements using real-world data.
Researchers specify eligibility criteria, treatment strategies, treatment assignment, follow-up period, outcomes, and analysis methods before examining the observational data. This helps reduce common sources of bias caused by vague study definitions.
Target trial emulation is particularly useful when a randomized trial would be difficult, expensive, unethical, or impractical. It can help researchers organize observational studies around a clearly defined causal question rather than relying primarily on associations found in available databases.
Causal Inference in Precision Medicine
The integration of causal inference with precision medicine represents an important emerging direction. Modern healthcare increasingly combines EHRs, genomics, medical imaging, biomarkers, wearable-device data, and other information sources.
The challenge is to determine not only which patient characteristics predict an outcome but which interventions are likely to change that outcome. A predictive model might identify patients at high risk of cardiovascular disease, for example, while a causal model could address whether a particular intervention would reduce that risk for a defined patient population.
This distinction has practical importance. Risk prediction alone does not establish that modifying a risk factor will improve outcomes. Causal reasoning is required to move from identifying risk to evaluating potential interventions.
Challenges in Establishing Causal Claims
Even advanced causal methods depend on assumptions. Researchers must consider whether important confounders have been measured, whether treatment definitions are sufficiently precise, whether outcomes are accurately recorded, and whether the population has adequate overlap across treatment groups.
Positivity, or the requirement that individuals with relevant characteristics have a nonzero probability of receiving each treatment option being compared, can be particularly challenging. If certain patients are almost always given one treatment and never another, the available data may provide little information about what would have happened under the alternative.
Another important issue is consistency between the causal question and the available data. If researchers want to estimate the effect of treatment adherence but only have prescription records, they may not have an accurate measure of whether patients actually took the medication. The resulting estimate may answer a different question from the one originally intended.
The Role of Reproducibility and Validation
Causal findings from real-world data require rigorous validation. Repeating an analysis in different healthcare databases can help determine whether results remain consistent across populations and clinical environments.
Sensitivity analyses are also essential. Researchers can examine how results change under different assumptions about unmeasured confounding, missing information, treatment definitions, and follow-up periods. Negative-control analyses and quantitative bias analyses can provide additional information about potential sources of bias.
External validation is particularly important when causal estimates are intended to inform clinical guidelines or policy. A result that appears robust within one healthcare system may change when applied to another population with different treatment practices, disease prevalence, or access to care.
The Future of Causal Healthcare Analytics
The future of causal inference will increasingly involve the integration of statistical methodology, machine learning, clinical expertise, and high-dimensional real-world data. Advances in EHR infrastructure, data standardization, computational methods, and artificial intelligence will provide researchers with increasingly sophisticated tools for analyzing healthcare processes.
However, methodological sophistication should not replace careful study design. The central principles of causal reasoning remain the same: define the intervention clearly, identify plausible confounding pathways, establish the relevant population, specify the outcome and follow-up period, assess assumptions, and communicate uncertainty.
Future healthcare analytics may increasingly move from descriptive dashboards and predictive risk scores toward systems capable of evaluating potential interventions. Such systems could help clinicians and policymakers understand not only who is at risk but also which actions may change outcomes under specific circumstances.
Conclusion
Causal inference with real-world healthcare data represents an important step beyond conventional statistical analytics. While traditional methods are valuable for describing associations and predicting outcomes, causal inference focuses on understanding the effects of interventions and exposures under clearly defined assumptions.
The complexity of healthcare makes this task particularly difficult. Confounding, selection bias, missing information, measurement error, treatment changes over time, heterogeneous patient populations, and differences in healthcare delivery can all affect causal estimates. Advanced methods such as propensity-based approaches, longitudinal causal models, target trial emulation, and causal machine learning provide valuable tools for addressing these challenges, but they cannot replace careful clinical reasoning and transparent assumptions.
The greatest opportunity lies in combining rigorous causal methodology with the scale and richness of modern real-world data. When researchers move beyond asking what is associated with an outcome and instead formulate precise questions about what would happen under alternative interventions, healthcare analytics can become more relevant to clinical decision-making. The future of data-driven medicine will therefore depend not simply on analyzing more information, but on developing reliable methods for distinguishing correlation from causation and translating observational evidence into carefully qualified conclusions about what may actually improve patient outcomes.